oseltamivir has been researched along with Virus Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aabenhus, R; Beutels, P; Bilcke, J; Bongard, E; Bruyndonckx, R; Bucher, HC; Butler, CC; Chlabicz, S; Coenen, S; Colliers, A; de Paor, M; De Sutter, A; Francis, N; Garcia-Sangenis, A; Glinz, D; Godycki-Cwirko, M; Goossens, H; Harbin, NJ; Kosiek, K; Li, X; Lindbæk, M; Lionis, C; Llor, C; Mikó-Pauer, R; Radzeviciene Jurgute, R; Seifert, B; Sundvall, PD; Touboul Lundgren, P; Tsakountakis, N; van der Velden, AW; Verheij, TJ | 1 |
| Fujisaki, S; Hashimoto, K; Hosoya, M; Katayose, M; Nemoto, K; Sakai, N; Sato, M; Takashita, E | 1 |
| Sacks, HS | 1 |
| Campbell, AP; Uyeki, TM | 1 |
| Dimopoulou, D; Douros, K; Papaevangelou, V; Pournaras, S; Vourli, S | 1 |
| Cárdenas, AM; Chang, YC; Feemster, K; Mitchell, SL | 1 |
| Carballal, G; Echavarría, M; Ekstrom, J; Marcone, DN; O'Farrell, C; Querci, M; Seoane, A; Vidaurreta, S; Videla, C; Ypas, M | 1 |
| Cai, L; Gao, D; Li, P; Liu, L; Ma, Y; Pan, H; Wang, C; Wang, H; Zhang, P; Zhang, Y | 1 |
| Boonlayangoor, S; Brielmaier, B; Charnot-Katsikas, A; Matushek, S; Pettit, NN; Pisano, J; Tesic, V | 1 |
| Heikkinen, T | 1 |
| Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH | 1 |
| Champey, Y; Faye, L | 1 |
| Blair, J; Burton, L; Choi, K; De Lima, C; Drews, SJ; Eshaghi, A; Lombos, E | 1 |
| Bischofberger, N; Laver, WG; Webster, RG | 1 |
| Keating, MR | 1 |
2 review(s) available for oseltamivir and Virus Diseases
| Article | Year |
|---|---|
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases | 2016 |
Antiviral agents for non-human immunodeficiency virus infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir | 1999 |
1 trial(s) available for oseltamivir and Virus Diseases
| Article | Year |
|---|---|
Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Emergency Service, Hospital; Female; Fluorescent Antibody Technique; Humans; Inappropriate Prescribing; Infant; Male; Middle Aged; Multiplex Polymerase Chain Reaction; Oligonucleotide Array Sequence Analysis; Oseltamivir; Prospective Studies; Respiratory Tract Infections; Virus Diseases; Viruses; Young Adult | 2018 |
12 other study(ies) available for oseltamivir and Virus Diseases
| Article | Year |
|---|---|
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC
Topics: Adolescent; Adult; Child; Cost-Benefit Analysis; Europe; Humans; Influenza, Human; Oseltamivir; Primary Health Care; Quality of Life; Quality-Adjusted Life Years; Virus Diseases | 2023 |
Clinical and Virologic Impacts of Respiratory Viral Co-infections in Children With Influenza.
Topics: Antiviral Agents; Child; Coinfection; Humans; Influenza, Human; Oseltamivir; Virus Diseases; Viruses | 2023 |
Adding oseltamivir to usual primary care reduced recovery time in influenza-like illness.
Topics: Antiviral Agents; Humans; Influenza, Human; Oseltamivir; Primary Health Care; Virus Diseases | 2020 |
Oseltamivir provides up to 3 days earlier time to recovery over usual care.
Topics: Antiviral Agents; Humans; Influenza, Human; Oseltamivir; Primary Health Care; Virus Diseases | 2020 |
Use of point-of-care molecular tests reduces hospitalization and oseltamivir administration in children presenting with influenza-like illness.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Emergency Service, Hospital; Female; Health Care Costs; Hospitalization; Humans; Immunoassay; Infant; Infant, Newborn; Influenza, Human; Male; Molecular Diagnostic Techniques; Oseltamivir; Point-of-Care Testing; Prospective Studies; Virus Diseases | 2021 |
Implementation of a rapid influenza A/B and RSV direct molecular assay improves emergency department oseltamivir use in paediatric patients.
Topics: Antiviral Agents; Child; Child Health; Child, Preschool; Emergency Service, Hospital; Female; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Molecular Diagnostic Techniques; Nasopharynx; Oseltamivir; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sensitivity and Specificity; Treatment Outcome; Virus Diseases | 2018 |
Noninvasive visualization of respiratory viral infection using bioorthogonal conjugated near-infrared-emitting quantum dots.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Female; HEK293 Cells; Humans; Influenza A Virus, H5N1 Subtype; Lung; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Nanotechnology; Oseltamivir; Powders; Quantum Dots; Spectrometry, Fluorescence; Spectroscopy, Near-Infrared; Tissue Distribution; Virus Diseases | 2014 |
Comparison of turnaround time and time to oseltamivir discontinuation between two respiratory viral panel testing methodologies.
Topics: Antiviral Agents; Early Diagnosis; Humans; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Oseltamivir; Reagent Kits, Diagnostic; Respiratory Tract Infections; Time Factors; Virus Diseases; Viruses | 2015 |
Respiratory viruses and children.
Topics: Antiviral Agents; Bacterial Infections; Child; Child, Preschool; Cost of Illness; Humans; Influenza, Human; Oseltamivir; Otitis Media; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Viral Vaccines; Virus Diseases | 2016 |
[Plants, medicine and genetics, which applications for tomorrow?].
Topics: Animals; Animals, Genetically Modified; Antiviral Agents; Escherichia coli; Genetic Diseases, Inborn; Genetics, Medical; Humans; Oseltamivir; Plants, Medicinal; Vaccines; Virus Diseases | 2008 |
A paucity of co-infecting respiratory viral pathogens in nasopharyngeal specimens from patients infected with H274Y-positive influenza A (H1N1) strains.
Topics: Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Nasopharynx; Neuraminidase; Ontario; Oseltamivir; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Viral Proteins; Virus Diseases; Viruses | 2009 |
Disarming flu viruses.
Topics: Amines; Animals; Antiviral Agents; Disease Outbreaks; Drug Design; Enzyme Inhibitors; Guanidines; Hemagglutinins; Humans; Influenza Vaccines; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrans; Sialic Acids; Virus Diseases; Virus Replication; Zanamivir | 1999 |